Kumquat Biosciences, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Ono Calls On PRISM For Oncology Di

Roche Holding AG , Genentech, Inc. and their affiliated companies were the busiest deal makers in the biopharmaceutical sector for the second consecutive year in 2021, with 23 deals across all cate

Eli Lilly and Company has been looking to add to the precision cancer therapy pipeline born out of its Loxo Oncology acquisition, and it is expanding those ambitions through a potentially wide-rangin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Seagen, RemeGen Partner Outside Asia, E